— Know what they know.
Not Investment Advice

GTH NASDAQ

Genetron Holdings Limited
1W: +0.5% 1M: +3.3% 3M: +9.5% 1Y: +34.3% 3Y: -92.6%
$4.03
Last traded 2024-03-28 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $127.3M mcap · 215M float · 0.024% daily turnover

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$651M +22.3% ▲
5Y CAGR: +45.1%
Gross Profit
$281M -16.7% ▼
5Y CAGR: +60.0%
Operating Income
-$632M -31.4% ▼
Net Income
-$884M -101.6% ▼
EPS (Diluted)
$-28.53 -499.4% ▼
EBITDA
-$651M -41.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$225M$323M$424M$532M$651M
YoY Growth+122.9%+43.6%+31.2%+25.3%+22.3%
Cost of Revenue$132M$178M$164M$194M$369M
Gross Profit$93M$145M$260M$338M$281M
Gross Margin41.2%44.8%61.3%63.5%43.2%
R&D Expenses$71M$92M$149M$254M$290M
SG&A Expenses$271M$371M$373M$570M$631M
Operating Expenses$332M$452M$514M$819M$913M
Operating Income-$233M-$307M-$254M-$481M-$632M
Operating Margin-103.5%-94.8%-59.7%-90.4%-97.1%
Interest Expense$0$5M$6M$5M$111M
Income Before Tax-$465M-$676M-$3.1B-$503M-$811M
Tax Expense-$232M-$355M-$2.9B-$64M$73M
Net Income-$465M-$321M-$198M-$438M-$884M
Net Margin-206.5%-99.4%-46.7%-82.4%-135.8%
EPS (Diluted)$-6.73$-4.65$-3.29$-4.76$-28.53
EBITDA-$212M-$626M-$202M-$460M-$651M
Shares Outstanding69M69M60M92M31M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms